Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 7.10.2019 | EN | Official Journal of the European Union | C 337/16 |

---

Action brought on 1 August 2019 – Nitto Pharmaceutical Industries v EUIPO – Chiesi Farmaceutici (NOSTER)

(Case T-550/19)

(2019/C 337/16)

Language of the case: English

Parties

Applicant: Nitto Pharmaceutical Industries Ltd (Kyoto, Japon) (represented by: P. Voutilainen, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Chiesi Farmaceutici SpA (Parma, Italy)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: International registration designating the European Union in respect of the word mark NOSTER – International registration designating the European Union No 1 332 950

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 May 2019 in Case R 2279/2018-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Art 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)